# A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)

> **NCT00308347** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1513 (actual)

## Conditions studied

- Type 2 Diabetes
- Nephropathy

## Interventions

- **DRUG:** MK0954, losartan / Duration of Treatment: mean 3.4 years
- **DRUG:** Placebo / Duration of Treatment: mean 3.4 years

## Key facts

- **NCT ID:** NCT00308347
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-05
- **Primary completion:** 2001-02
- **Final completion:** 2001-04
- **Target enrollment:** 1513 (ACTUAL)
- **Last updated:** 2022-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308347, "A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00308347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*